An apparently top-down new push to effectively decriminalize marijuana was the spark that lit Canopy Growth (NASDAQ: CGC) stock on Wednesday. That allowed the Canadian pot purveyor to easily surmount the hump of Hump Day, with its stock closing nearly 13% higher. That was a far better performance than the 0.4% rise of the S&P 500 index.
Before market open this morning, Bloomberg reported that an unnamed “top official” at the government’s Department of Health and Human Services (HHS) formally requested that marijuana be reclassified as a far less threatening drug than at present.
The HHS official addressed the letter to the Drug Enforcement Agency’s (DEA) administrator, Anne Milgram. Bloomberg wrote that it had seen the letter, and a DEA spokesperson it did not name acknowledged the agency received it.
The DEA classifies drugs according to a set of “schedules.” A Schedule I substance like marijuana has “no currently accepted medical use and a high potential for abuse” and is, thus, considered dangerous. Marijuana is joined by heroin and LSD in this classification.
Down the ladder, Schedule III drugs hold “a moderate to low potential for physical and psychological dependence.” This list is populated by formulations such as testosterone and anabolic steroids.
That DEA spokesperson contacted for the article said the agency would initiate a review into the matter. This doesn’t, of course, mean that America is about to throw the switch on full-throttle marijuana legalization just yet. The wheels of government, particularly the federal government, turn slowly.
But it’s an indication of just how strong the support for pot decriminalization has become that an influential health official is openly advocating for change. Canadian cannabis companies, hamstrung as they are by their ever-struggling domestic market, would very much benefit from serious U.S. weed reform.
Here’s The Marijuana Stock You’ve Been Waiting For
A little-known Canadian company just unlocked what some experts think could be the key to profiting off the coming marijuana boom.
And make no mistake – it is coming.
Cannabis legalization is sweeping over North America – 19 states plus Washington, D.C., have all legalized recreational marijuana over the last few years, and full legalization came to Canada in October 2018.
And one under-the-radar Canadian company is poised to explode from this coming marijuana revolution.
Because a game-changing deal just went down between the Ontario government and this powerhouse company…and you need to hear this story today if you have even considered investing in pot stocks.
Simply click here to get the full story now.
Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
—
Blog powered by G6
Disclaimer! A guest author has made this post. G6 has not checked the post. its content and attachments and under no circumstances will G6 be held responsible or liable in any way for any claims, damages, losses, expenses, costs or liabilities whatsoever (including, without limitation, any direct or indirect damages for loss of profits, business interruption or loss of information) resulting or arising directly or indirectly from your use of or inability to use this website or any websites linked to it, or from your reliance on the information and material on this website, even if the G6 has been advised of the possibility of such damages in advance.
For any inquiries, please contact [email protected]
